The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Invariant NKT (iNKT) cells bridge innate and acquired immunity and play an important role in both protective and regulatory responses. The nature of the response is dictated by the initial cytokine environment: interaction with IL-10-producing cells induces negative regulatory T(h)2/regulatory T cell-type iNKT cells, while that with IL-12-producing cells results in pro-inflammatory T(h)1-type responses. Particularly, in the anti-tumor response, iNKT cells mediate adjuvant activity by their production of IFN-gamma, which in turn activates both innate and acquired immune systems. Thus, upon activation of iNKT cells, both MHC(-) and MHC(+) tumor cells can be efficiently eliminated. On the basis of these mechanisms, iNKT cell-targeted adjuvant cell therapies have been developed and have shown great promise in initial clinical trials on cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997) · Science · doi:10.1126/science.278.5343.1626 · Cited by 2,400
Self-citationLysosomal Glycosphingolipid Recognition by NKT Cells
Zhou, D., Mattner, J., Cantu, C., Schrantz, N., Yin, N., Gao, Y., Sagiv, Y., Hudspeth, K., Wu, Y.-P., Yamashita, T., et al. (2004) · Science · doi:10.1126/science.1103440 · Cited by 956
Cited by
Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells
Najar, M., Raicevic, G., Fayyad-Kazan, H., Bron, D., Toungouz, M., & Lagneaux, L. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2015.10.011 · Cited by 267
Hogan, A. E., Tobin, A. M., Ahern, T., Corrigan, M. A., Gaoatswe, G., Jackson, R., O’Reilly, V., Lynch, L., Doherty, D. G., Moynagh, P. N., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2232-3 · Cited by 191
Natural killer T cell subsets in eutopic and ectopic endometrium: a fresh look to a busy corner
Laganà, A. S., Triolo, O., Salmeri, F. M., Granese, R., Palmara, V. I., Ban Frangež, H., Vrtčnik Bokal, E., & Sofo, V. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-4004-7 · Cited by 67
Gaoatswe, G., Kent, B. D., Corrigan, M. A., Nolan, G., Hogan, A. E., McNicholas, W. T., & O'Shea, D. (2015) · Sleep · doi:10.5665/sleep.5062 · Cited by 44
Metadata
- Authors
- Taniguchi, M., Tashiro, T., Dashtsoodol, N., Hongo, N., & Watarai, H.
- Venue
- International Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-10-25
- Volume
- 22
- Issue
- 1
- Pages
- 1-6
- ISSN
- 0953-8178 (ISSN-L)
- 1460-2377
- OpenAlex
- W2096318175
- Cited by
- 70
- References
- 2
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy. https://app.cochat.ai/papers/10.1093/intimm/dxp104
- The paper
- Taniguchi, M., Tashiro, T., Dashtsoodol, N., Hongo, N., & Watarai, H. (2010). The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy. International Immunology. https://doi.org/10.1093/intimm/dxp104
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.